News Focus
News Focus
icon url

HDGabor

03/29/15 9:51 AM

#46156 RE: Biobillionair #46153

Amarin never benefited from the exclusivity


AMRN HAS the exclusivity! The case is not about the beginning it is about the end date. AMRN could market Vascepa on an exclusive basis, since 7/26/2012.